Verily Receives $1B Investment to Support Partnerships, Acquisitions

Jan. 4, 2019
Verily, an Alphabet company, announced a $1 billion investment round, led by global technology investment firm Silver Lake, to support investments in healthcare and life sciences strategic partnerships and potential acquisitions.

Verily, an Alphabet company, announced a $1 billion investment round, led by global technology  investment firm Silver Lake, to support investments in healthcare and life sciences strategic partnerships and potential acquisitions.

 Other new investors in the round include Ontario Teachers’ Pension Plan and other global investment management firms. Ruth Porat, chief financial officer at Alphabet, and Egon Durban, managing partner and managing director of Silver Lake, will be nominated to join Verily’s operating board.

“We are taking external funding to increase flexibility and optionality as we expand on our core strategic focus areas,” said Andrew Conrad, CEO of Verily, in a prepared statement. “Adding a well-rounded group of seasoned investors, led by Silver Lake, will further prepare us to execute as healthcare continues the shift towards evidence generation and value-based reimbursement models.”

South San Francisco-based Verily has described its dual objectives as creating tools and user-friendly platforms that capture a deeper and broader set of health data and organizing the data so that it is useful and actionable.

In December Verily announced that it would work with Walgreens Boots Alliance Inc. to develop a medication adherence pilot project. Walgreens and Verily will deploy devices and other approaches designed to improve medication adherence. Walgreens, together with Onduo, Verily’s joint venture with Sanofi, will also launch a virtual diabetes solution to Walgreens employees and family members with Type 2 diabetes through the Walgreens employee health plan. Onduo provides tools, coaching and remote access to specialty doctors to help people with diabetes to manage their condition anytime, anywhere.

Walgreens said it would become a retail pharmacy development and commercialization partner to Verily, and the organizations have agreed to work on and explore ways to improve access to advanced healthcare technologies and solutions – which may include sensors and software to help prevent, manage, screen and diagnose disease – with a shared goal of scaling deployment at Walgreens retail locations.

In Juy 2018 Verily announced a joint venture with ResMed to study the health and financial impacts of undiagnosed and untreated sleep apnea, and develop software solutions that enable healthcare providers to more efficiently identify, diagnose, treat and manage individuals with sleep apnea and other breathing related sleep disorders.

Sponsored Recommendations

Cloud Communications: Connecting Care at the Core

Cloud communications is the present, the recent past, and the future of collaborative healthcare.

The Ultimate HIPAA Security Guide for Cloud Communications

The healthcare industry is leading the charge in innovation, embracing cutting-edge technologies to enhance patient care and optimize operations. Forward-thinking organizations...

Improving Workplace Safety and Patient Care in Behavioral Health

In 2023, Vail Health enhanced safety in their behavioral health clinic, but the impact went beyond their expectations. Read their case study to see how prioritizing workplace ...

Transforming Hospital Capacity Through Smarter Patient Progression Strategies

Helping patients move seamlessly through every stage of their care, from admission to discharge, is critical to ensuring patient safety, improving outcomes, and optimizing capacity...